Bioatla Inc (BCAB)

Jan 15, 2025

Jane Street Group LLC Decreases Position in BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jan 15, 2025

Jan 14, 2025

BioAtla (NASDAQ:BCAB) Stock Price Down 6.1% – Here’s Why - Defense World

Jan 14, 2025

Jan 08, 2025

Bioatla stock hits 52-week low at $0.57 amid sharp decline - Investing.com

Jan 08, 2025

Jan 08, 2025

Bioatla stock hits 52-week low at $0.57 amid sharp decline By Investing.com - Investing.com South Africa

Jan 08, 2025

Jan 02, 2025

BioAtla (BCAB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jan 02, 2025

Dec 22, 2024

**BioAtla Updates Corporate Presentation in 8-K Filing** - Defense World

Dec 22, 2024

Dec 21, 2024

BioAtla Announces Registered Direct Offering to Advance Clinical Programs to Key Inflection PointsSan Diego, Calif., December 20, 2024 – BioAtla, Inc. (NASDAQ: BCAB), a global clinical-stage biotechnology company, disclosed on December 19, 2024, that - Defense World

Dec 21, 2024

Dec 20, 2024

Bioatla stock hits 52-week low at $1.02 amid market challenges - Investing.com Australia

Dec 20, 2024

Dec 20, 2024

BioAtla Secures $9.2M for Clinical Program Advancements - TipRanks

Dec 20, 2024

Dec 20, 2024

BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points - The Manila Times

Dec 20, 2024

Dec 20, 2024

BioAtla Highlights Advancements in CAB Cancer Therapy - TipRanks

Dec 20, 2024

Dec 20, 2024

BioAtla announces $9.2 million stock and warrant sale - Investing.com

Dec 20, 2024

Dec 20, 2024

BioAtla announces $9.2 million stock and warrant sale By Investing.com - Investing.com Canada

Dec 20, 2024

Dec 20, 2024

BioAtla announces registered direct offering to advance two mid-stage clinical programs, shares fall - Seeking Alpha

Dec 20, 2024

Dec 20, 2024

BioAtla Secures $9.2M Funding Through Strategic Stock Offering to Advance Clinical Programs - StockTitan

Dec 20, 2024

Dec 18, 2024

Insiders Give Up US$66k As BioAtla Stock Drops To US$1.31 - Yahoo Finance

Dec 18, 2024

Dec 16, 2024

BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting - The Manila Times

Dec 16, 2024

Dec 16, 2024

BioAtla's Lung Cancer Drug Shows Promising 58% One-Year Survival Rate in Key Clinical Data - StockTitan

Dec 16, 2024

Dec 15, 2024

BioAtla's SWOT analysis: oncology biotech stock faces pivotal year By Investing.com - Investing.com South Africa

Dec 15, 2024

Dec 15, 2024

BioAtla's SWOT analysis: oncology biotech stock faces pivotal year - Investing.com

Dec 15, 2024

Dec 10, 2024

BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting - Quantisnow

Dec 10, 2024

Nov 20, 2024

BioAtla, Inc. (NASDAQ:BCAB) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024

Nov 19, 2024

Michael Burry's Scion fund exits BioAtla, boosts Alibaba stake, adds puts: top Q3 trades - MSN

Nov 19, 2024

Nov 19, 2024

GSA Capital Partners LLP Purchases New Position in BioAtla, Inc. (NASDAQ:BCAB) - MarketBeat

Nov 19, 2024

Nov 18, 2024

BioAtla, Inc. (NASDAQ:BCAB) Sees Significant Drop in Short Interest - MarketBeat

Nov 18, 2024

Nov 16, 2024

HC Wainwright Weighs in on BioAtla FY2024 Earnings - Defense World

Nov 16, 2024

Nov 15, 2024

FY2024 Earnings Estimate for BioAtla Issued By HC Wainwright - MarketBeat

Nov 15, 2024

Nov 15, 2024

Analysis of TANG CAPITAL MANAGEMENT LLC's Recent Transaction in BioAtla Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

BioAtla (NASDAQ:BCAB) Rating Lowered to Neutral at HC Wainwright - Defense World

Nov 15, 2024

Nov 14, 2024

Michael Burry's Scion fund exits BioAtla, boosts Alibaba stake, adds puts: top Q3 trades (HPP:NYSE) - Seeking Alpha

Nov 14, 2024

Nov 14, 2024

HC Wainwright & Co. Downgrades BioAtla (BCAB) - MSN

Nov 14, 2024

Nov 13, 2024

BioAtla (NASDAQ:BCAB) Downgraded to "Neutral" Rating by HC Wainwright - MarketBeat

Nov 13, 2024

Nov 09, 2024

BioAtla Inc (BCAB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada

Nov 09, 2024

Nov 09, 2024

Head to Head Review: Alector (NASDAQ:ALEC) vs. BioAtla (NASDAQ:BCAB) - Defense World

Nov 09, 2024

Nov 08, 2024

3 Promising US Penny Stocks With At Least $90M Market Cap - Simply Wall St

Nov 08, 2024

Nov 08, 2024

BioAtla Reports Q3 2024 Financial Results and Clinical Advances - TipRanks

Nov 08, 2024

Nov 07, 2024

BioAtla reports Q3 EPS (22c), consensus (36c) - TipRanks

Nov 07, 2024

Nov 07, 2024

BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress - StockTitan

Nov 07, 2024

Nov 01, 2024

BioAtla (BCAB) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 01, 2024

Oct 31, 2024

BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024 - The Manila Times

Oct 31, 2024

Oct 30, 2024

BioAtla, Inc. (NASDAQ:BCAB) has caught the attention of institutional investors who hold a sizeable 39% stake - Yahoo Finance UK

Oct 30, 2024

Oct 28, 2024

BioAtla, Inc. (NASDAQ:BCAB) Short Interest Update - MarketBeat

Oct 28, 2024